North & South America

North & South America

Argentina

Local distributor

Argentina

Canada
EN | FR
Colombia

Local distributor

Colombia

Perù

Local distributor

Perù

Uruguay

Local distributor

Uruguay

Venezuela

Local distributor

Venezuela

Europe

Europa

Bosnia-Herzegowina

Local distributor

Bosnia-Herzegowina

Bulgaria

Local distributor

Bulgaria

Croatia

Local distributor

Croatia

Greece

Local distributor

Greece

Hungary

Local distributor

Ungheria

Malta

Local distributor

Malta

Romania

Local distributor

Romania

Serbia

Local distributor

Serbia

Slovenia

Local distributor

Slovenia

Eastern Europe, Middle East & Africa

Eastern Europe, Middle East & Africa

Estonia

Local distributor

Estonia

Ethiopia

Local distributor

Ethiopia

Ghana

Local distributor

Ghana

Israel

Local distributor

Israel

Jordan

Local distributor

Jordan

Kenya

Local distributor

Kenya

Lebanon

Local distributor

Lebanon

Latvia

Local distributor

Latvia

Lithuania

Local distributor

Lithuania

Mauritius

Local distributor

Mauritius

Russia

Local distributor

Russia

Saudi Arabia

Local distributor

Saudi Arabia

South Africa

Local distributor

South Africa

Uganda

Local distributor

Uganda

United Arab Emirates

Local distributor

United Arab Emirates

Asia Pacific

Asia Pacific

Australia

Local distributor

Australia

Taiwan - China

Local distributor

Taiwan - China

India

Local distributor

India

Indonesia

Local distributor

Indonesia

New Zealand

Local distributor

New Zealand

Pakistan

Local distributor

Pakistan

Philippines

Local distributor

Philippines

Singapore

Local distributor

Singapore

Thailand

Local distributor

Thailand

Vietnam

Local distributor

Vietnam

 

Select your country

Asia

Australia

Local distributor

Australia

India

Local distributor

India

Indonesia

Local distributor

Indonesia

New Zealand

Local distributor

New Zealand

Pakistan

Local distributor

Pakistan

Philippines

Local distributor

Philippines

Singapore

Local distributor

Singapore

Thailand

Local distributor

Thailand

Vietnam

Local distributor

Vietnam

North & South America

Argentina

Local distributor

Argentina

Colombia

Local distributor

Colombia

Perù

Local distributor

Perù

Uruguay

Local distributor

Uruguay

Venezuela

Local distributor

Venezuela

Europe

Bosnia-Herzegowina

Local distributor

Bosnia-Herzegowina

Bulgaria

Local distributor

Bulgaria

Croatia

Local distributor

Croatia

Greece

Local distributor

Greece

Romania

Local distributor

Romania

Serbia

Local distributor

Serbia

Slovenia

Local distributor

Slovenia

Ungheria

Local distributor

Ungheria

Eastern Europe, Middle East & Africa

Ethiopia

Local distributor

Ethiopia

Ghana

Local distributor

Ghana

Israel

Local distributor

Israel

Jordan

Local distributor

Jordan

Kenya

Local distributor

Kenya

Lebanon

Local distributor

Lebanon

Mauritius

Local distributor

Mauritius

Saudi Arabia

Local distributor

Saudi Arabia

South Africa

Local distributor

South Africa

Uganda

Local distributor

Uganda

Ukraine

Local distributor

Ukraine

GLOBAL

Bracco Imaging Announces Global Collaboration Agreement with Guerbet

Milan , 14/12/2021

Earlier today, Bracco Imaging announced a global strategic collaboration agreement with Guerbet for Gadopiclenol, a high-relaxivity, macrocyclic contrast agent. Bracco Imaging and Guerbet will manufacture, as well as support research and development for future indications of Gadopiclenol, which the parties will commercialize independently under different brands.

Bracco Imaging and Guerbet both own valuable intellectual property Gadopiclenol. In March 2021, positive results from two Phase III studies comparing the diagnostic efficacy and safety of Gadopiclenol, which uses half the dose of gadolinium compared to Gadobutrol, in a wide range of indications, covering the central nervous system and various other anatomical areas (head and neck, thorax, breast, abdomen, pelvis, musculoskeletal system) were published by Guerbet. The first marketing authorizations are anticipated in 2023, initially in the United States and the European Union (EU), with other geographies to follow.

The decision to collaborate with Guerbet on Gadopiclenol expands Bracco Imaging’s already strong MRI offering which, once approved, will include a total of three different products to address global medical needs. Additionally, through this collaboration, our goal is to accelerate our capabilities and explore untapped research for an agent that has the potential to offer earlier detection, and which could result in meaningful health benefits.

For any questions, please reach out to Duccio Manetti, Global Communication Director of Bracco Imaging at Duccio.manetti@bracco.com.